TAIZHOU CITY, ZHEJIANG, CHINA, July 22, 2026 /EINPresswire.com/ — On June 1, Haisco Pharmaceutical Group announced that its proprietary innovative intravenous anesthetic, Cipepofol Injection (CYPSEDO) ...
By Chris Prentice and Mariam Sunny NEW YORK, July 22 (Reuters) - Many patients have opted for injectable forms of the wildly ...
Pharmaceutical companies warn Australia’s complex approvals process is turning off drug companies, as the Trump ...
July 20 (Reuters) - Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making ...
Dr Reddy's expects to resume semaglutide supplies by November after resolving quality issues. The company identified the root ...
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and ...
The Maine Monitor on MSN
How two rural Maine jails are rethinking addiction treatment
Monthly shots to treat addiction are promising, but costly.
Hundreds of new medicines remain stuck without pricing approval, leaving patients waiting while companies see investments frozen ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano today announced the publication of a comprehensive peer-reviewed study in Biomedicines describing the preclinical translational package ...
D-150 gene therapy enters pivotal Wet-AMD/DME trials, cutting injections up to 89%. Click for this FDMT update.
US exports accounted for 46.16 per cent of Aurobindo Pharma's sales in FY26. For Sun Pharma, 30.26 per cent of its revenues came from US in FY26, as per Bloomberg data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results